Top Stories

Get Ready for CPhI Worldwide 2015

Planning ahead is the key to a successful visit to CPhI Worldwide 2015. Pharmaceutical Technology Europe interviewed Rutger Oudejans, Brand Director Pharma at UBM EMEA—the organizer of CPhI—to gain insight into the activities at CPhI Worldwide 2015 and best practices attendees can apply to accomplish business objectives at the event.
/ read more /

Pharma’s Supply Chain Crisis and the Myth of Globalization

Hedley Rees, managing director at PharmaFlow Ltd and a member of the CPhI expert panel, shares his views on pharmaceutical supply chain issues.
/ read more /

CPhI NEWS

Highlights at CPhI Worldwide 2015

The 26th annual CPhI Worldwide exhibition and co-located events—ICSE, InnoPack, and P-Mec—bring together pharmaceutical industry professionals from around the world to view equipment and services exhibits, attend educational conferences, network with industry peers, and conduct business.
/ read more /

Exhibits Display Emerging Technologies

Fine chemicals, APIs, excipients, manufacturing equipment, laboratory instruments, packaging systems, and contract services are on display in the 11 exhibit halls of CPhI Worldwide and co-located events ICSE, InnoPak, P-MEC, and LABWorld 2015.
/ read more /

Clariant to Showcase Pharma Polymers and Packaging Solutions at CPhI Worldwide 2015

Exhibits include controlled atmosphere packaging for protection against moisture and oxygen, as well as specialty polymers and active ingredients for healthcare applications, among others.
/ read more /

Avantor to Feature New Excipients and Packaging Options at CPhI Worldwide 2015

Avantor’s featured products at this year’s CPhI include the new high-purity, low-endotoxin sugars, the new Direct Dispense proprietary packaging platform, and the J.T.Baker Bakerbond process chromatography media.
/ read more /

FEATURED TOPICS

Collaborating on GMP Inspections

EU and US regulators are striving to work together on improving GMP inspection efficiencies and avoiding duplication of efforts.
/ read more /

Lack of Expertise Hinders Adoption of Continuous API Synthesis

FDA, Congress, and early adopters look to speed up the use of continuous API manufacturing.
/ read more /

Excipient Selection for Protein Stabilization

The complex task of stabilizing proteins is made more challenging due to the limited number of approved excipients.
/ read more /

Establishing Limits for Dermal Absorption of Elemental Impurities

Current guidance for absorption of elemental impurities does not address dermal exposure, resulting in a simplistic approach to limit setting; available information shows that exposure to low-level elemental impurities is unlikely to be a substantive concern for topical drug products.
/ read more /